Ann: AusCann Releases Low-dose Form Capsule, page-34

First 34 Last

Share
Profile

Follow
fyou

1,155 Posts.

75

19/02/20

18:00

Post #: 43027963
Share

Originally posted by Pledge: ↑

If you look at the announcement from Dec 2019 and then read this announcement, I think we can safely deduce (IMO) that the trial(s) is scheduled to occur between now and the expected release of finalized product to market (by the end of June 2020).

This is what Ido stated 18 Dec 2019: “We remain focused on making AusCann’s capsules available for prescription to patients in Australia during the first half of 2020. Our goal is to provide high-quality medicine and to obtain detailed, data-driven evaluations regarding the outcomes of AusCann’s pharmaceutical treatment. These results will build the clinical evidence supporting the unique benefits of AusCann’s capsules necessary to open a large market for the Company.”

The guidance criteria has been stated in this release "The Therapeutic Goods Administration’s (TGA) guidance document1 suggests that the general principle for medicinal cannabis dosing should be “start low, go slow”. ". If that's what the TGA has said, then that's the approach that should be taken.

Ido has also stated in this release “Reliable, stable and standardised medicines are critical in order to generate quality clinical evidence for cannabinoid-based medicines. This evidence is a prerequisite to market expansion and medical acceptance by healthcare professionals. We remain committed to making our dose-controlled capsules commercially available for prescription to patients in Australia in the first half of 2020 through the TGA special access scheme and authorised prescriber scheme.”

It seems straight forward to me. Could it change and/or be delayed? Yes, but it doesn't look that way to me at this point? My take away from this recent release is that things are still on track and that AC8 will be starting low in dosing potency.

I think Fyou has me on block - ha ha ha! Someone with a handle of "Fyou" has blocked someone - that made me laugh! Fyou too, hey - ha ha ha. 彼は知らない

All IMO DYOR.

Expand

いえ、その事はありません、

ありがとうございます

AC8 Price at posting: 30.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Shekel Brainweigh and Calmer Co lead innovations in the retail space

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

There are more pages in this discussion • 31 more messages in this thread...

First 34 Last

Add AC8 (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $17.62M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: AusCann Releases Low-dose Form Capsule, page-34

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Featured News

Ann: AusCann Releases Low-dose Form Capsule, page-34

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Shekel Brainweigh and Calmer Co lead innovations in the retail space

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Featured News

Featured News